Brind.

Exact Sciences and Novartis both reported positive Earnings ESP on July 24, 2025.

1 report, 1 independent Updated Jul 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Exact Sciences Novartis

Keep exploring

The entities involved

Exact Sciences
American company in Madison, United States
- Zacks Investment Research provided stock analysis and ratings for Exact Sciences.Sun 06:59
Novartis
Swiss-American multinational pharmaceutical corporation
- Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
- GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16

Related events

Bank of America maintained its Buy rating on Novartis shares.Sep 11

Coverage

Newest first; wire copies grouped

Jul 24ZacksHow to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and wh